EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NAT10 inhibition promotes ac4C‐dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma

Ziyi Xue, Haijing Xie, Ying Shan, Lin Zhang, Lin Cheng, Wenyue Chen, Rui Zhu, Kaiwen Zhang, Haosheng Ni iD, Zhenxin Zhang, Yiwen You iD, Bo You iD

Cancer Science · 2024

DOI: 10.1111/cas.16249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Ziyi Xue und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nantong University, Nantong, Jiangsu Province, China. Hauptthemen laut MEDLINE: Sorafenib, Nasopharyngeal Carcinoma, Drug Resistance, Neoplasm, Ferroptosis. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Special scientific research Project of Nantong Health Commission, Jiangsu Provincial Medical Key Discipline(Laboratory) Cultivation Unit, Jiangsu Provincial Research Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sorafenib, an anticancer drug, has been shown to induce ferroptosis in cancer cells. However, resistance to sorafenib greatly limits its therapeutic efficacy, and the exact mechanism of resistance is not fully understood. This study investigated the role of N‐Acetyltransferase 10 (NAT10) in influencing the anticancer activity of sorafenib in nasopharyngeal carcinoma (NPC) and its molecular mechanism. NAT10 expression was significantly upregulated in NPC. Mechanistically, NAT10 promotes proteins of solute carrier family 7 member 11 (SLC7A11) expression through ac4C acetylation, inhibiting sorafenib‐induced ferroptosis in NPC cells. The combined application of sorafenib and the NAT10 inhibitor remodelin significantly inhibits SLC7A11 expression and promotes ferroptosis in NPC cells. In vivo knockout of NAT10 inhibited the growth of sorafenib‐resistant NPC. Our findings suggest that NAT10 inhibition might be a promising therapeutic approach to enhance the anticancer activity of sorafenib.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibNasopharyngeal CarcinomaDrug Resistance, NeoplasmFerroptosisNasopharyngeal NeoplasmsAmino Acid Transport System y+HumansCell Line, TumorAnimalsMiceAntineoplastic AgentsXenograft Model Antitumor AssaysAcetyltransferasesGene Expression Regulation, NeoplasticMice, NudeMaleAcetylationFemale

Stichwörter der Autor:innen

NAT10SLC7A11ferroptosisnasopharyngeal carcinomasorafenib resistance

Substanzen

SorafenibSLC7A11 protein, humanAmino Acid Transport System y+Antineoplastic AgentsAcetyltransferases

Autor:innen und Institutionen

  • Nantong University, Nantong, Jiangsu Province, China.
  • Institute of Otolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.
  • Department of Otolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.
  • Haimen People's Hospital, Nantong, Jiangsu Province, China.

ORCID-Profile: Haosheng Ni, Yiwen You, Bo You

Förderung

  • Special scientific research Project of Nantong Health Commission
  • Jiangsu Provincial Medical Key Discipline(Laboratory) Cultivation Unit
  • Jiangsu Provincial Research Hospital
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • CSCO Clinical Oncology Research Foundation of Beijing

Zitieren

APA

Xue, Z., Xie, H., Shan, Y., Zhang, L., Cheng, L., Chen, W., Zhu, R., Zhang, K., Ni, H., Zhang, Z., You, Y., & You, B. (2024). NAT10 inhibition promotes ac4C‐dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. Cancer Science. https://doi.org/10.1111/cas.16249

Vancouver

Xue Z, Xie H, Shan Y, Zhang L, Cheng L, Chen W, et al. NAT10 inhibition promotes ac4C‐dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. Cancer Science. 2024. doi:10.1111/cas.16249

BibTeX
@article{Xue2024,
  author = {Xue, Ziyi and Xie, Haijing and Shan, Ying and Zhang, Lin and Cheng, Lin and Chen, Wenyue and Zhu, Rui and Zhang, Kaiwen and Ni, Haosheng and Zhang, Zhenxin and You, Yiwen and You, Bo},
  title = {NAT10 inhibition promotes ac4C‐dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16249}
}
Kostenlos starten →